Skip to main content
Top
Published in: Journal of Cancer Education 6/2019

01-12-2019

Increasing Awareness of Uterine Cancer Risks and Symptoms by Using Campaign Materials from Inside Knowledge: Get the Facts About Gynecologic Cancer

Authors: Daniel Novinson, Mary Puckett, Julie Townsend, Guillermo Tortolero-Luna, Jenny Rees Patterson, Cynthia A. Gelb, Sherri L. Stewart

Published in: Journal of Cancer Education | Issue 6/2019

Login to get access

Abstract

Uterine cancer is the fourth most commonly diagnosed cancer among women in the USA. To increase knowledge among women and healthcare providers about uterine cancer, the Centers for Disease Control and Prevention’s National Comprehensive Cancer Control Program (NCCCP) partnered with the Inside Knowledge: Get The Facts About Gynecologic Cancer campaign to present facilitated discussions about uterine cancer with women and providers. After standardized training, local NCCCP grantees developed and led community-based, tailored, facilitated discussions for public participants and providers. Pre- and post-session surveys were administered to assess knowledge of risk factors, symptoms, testing, and diagnostic options for uterine cancer. Following the facilitated sessions, significantly, more public respondents identified uterine cancer risk factors (e.g., advanced age, post-menopausal status). However, they also equally identified factors not associated with uterine cancer (e.g., smoking, HPV). Non-OB/GYN provider knowledge increased, significantly for some risks and symptoms, and their confidence with relaying uterine cancer information to patients significantly increased from 51.4 to 91.0% (P < 0.0001). Relatively low proportions of OB/GYNs (19.3%), other primary care providers (46.2%), and public participants (51.8%) knew post-session that genetic testing for Lynch syndrome can help stratify women for uterine cancer risk. Participant knowledge significantly increased for some risk factors and symptoms following Inside Knowledge educational sessions; however, some knowledge gaps remained. Overall, the Inside Knowledge materials are effective for increasing uterine cancer awareness among providers and women. Additional provider education could include specific resources related to uterine cancer genetic associations, as advancements in genetic testing for all uterine cancers are currently being made.
Literature
1.
go back to reference Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179–211CrossRef Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179–211CrossRef
2.
go back to reference Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84(2):191–215CrossRef Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84(2):191–215CrossRef
3.
go back to reference Cooper CP, Polonec L, Gelb CA (2011) Women's knowledge and awareness of gynecologic cancer: a multisite qualitative study in the United States. J Women's Health (Larchmt) 20(4):517–524CrossRef Cooper CP, Polonec L, Gelb CA (2011) Women's knowledge and awareness of gynecologic cancer: a multisite qualitative study in the United States. J Women's Health (Larchmt) 20(4):517–524CrossRef
4.
go back to reference Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ (2017) Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Hum Pathol 70:121–128CrossRef Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ (2017) Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Hum Pathol 70:121–128CrossRef
5.
go back to reference Goverde A, Spaander MC, van Doorn HC, Dubbink HJ, van den Ouweland AM, Tops CM, Kooi SG, de Waard J, Hoedemaeker RF, Bruno MJ, Hofstra RM, de Bekker-Grob EW, Dinjens WN, Steyerberg EW, Wagner A, L. s. group (2016) Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. Gynecol Oncol 143(3):453–459CrossRef Goverde A, Spaander MC, van Doorn HC, Dubbink HJ, van den Ouweland AM, Tops CM, Kooi SG, de Waard J, Hoedemaeker RF, Bruno MJ, Hofstra RM, de Bekker-Grob EW, Dinjens WN, Steyerberg EW, Wagner A, L. s. group (2016) Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. Gynecol Oncol 143(3):453–459CrossRef
6.
go back to reference Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85(2):304–313CrossRef Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85(2):304–313CrossRef
7.
go back to reference Hayden JA (2014) Introduction to health behavior theory. Jones and Bartlett Learning, Burlington Hayden JA (2014) Introduction to health behavior theory. Jones and Bartlett Learning, Burlington
8.
go back to reference Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual report to the nation on the status of Cancer, 1975-2014, featuring survival. J Natl Cancer Inst 109(9) Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual report to the nation on the status of Cancer, 1975-2014, featuring survival. J Natl Cancer Inst 109(9)
9.
go back to reference Knowles MA (2005) The adult learner: the definitive classic in adult education and human resource development. Elsevier, BurlingtonCrossRef Knowles MA (2005) The adult learner: the definitive classic in adult education and human resource development. Elsevier, BurlingtonCrossRef
10.
go back to reference Koldjeski D, Kirkpatrick MK, Everett L, Brown S, Swanson M (2004) Health seeking related to ovarian cancer. Cancer Nurs 27(5):370–378 quiz 379–380CrossRef Koldjeski D, Kirkpatrick MK, Everett L, Brown S, Swanson M (2004) Health seeking related to ovarian cancer. Cancer Nurs 27(5):370–378 quiz 379–380CrossRef
11.
go back to reference Leenen CH, Goverde A, de Bekker-Grob EW, Wagner A, van Lier MG, Spaander MC, Bruno MJ, Tops CM, van den Ouweland AM, Dubbink HJ, Kuipers EJ, Dinjens WN, van Leerdam ME, Steyerberg EW (2016) Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age. Genet Med 18(10):966–973CrossRef Leenen CH, Goverde A, de Bekker-Grob EW, Wagner A, van Lier MG, Spaander MC, Bruno MJ, Tops CM, van den Ouweland AM, Dubbink HJ, Kuipers EJ, Dinjens WN, van Leerdam ME, Steyerberg EW (2016) Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age. Genet Med 18(10):966–973CrossRef
12.
go back to reference Mahdi H, Han X, Moulton L, Vargas R (2017) Trends in survival of patients with uterine serous carcinoma from 1988 to 2011: a population-based study. Int J Gynecol Cancer 27(6):1155–1164CrossRef Mahdi H, Han X, Moulton L, Vargas R (2017) Trends in survival of patients with uterine serous carcinoma from 1988 to 2011: a population-based study. Int J Gynecol Cancer 27(6):1155–1164CrossRef
13.
go back to reference Major A, Stewart SL (2009) Celebrating 10 years of the National Comprehensive Cancer Control Program, 1998 to 2008. Prev Chronic Dis 6(4):A133PubMedPubMedCentral Major A, Stewart SL (2009) Celebrating 10 years of the National Comprehensive Cancer Control Program, 1998 to 2008. Prev Chronic Dis 6(4):A133PubMedPubMedCentral
14.
go back to reference Merrill RM (2008) Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 14(1):CR24–CR31PubMed Merrill RM (2008) Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 14(1):CR24–CR31PubMed
15.
go back to reference Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38(11):1501–1509CrossRef Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38(11):1501–1509CrossRef
16.
go back to reference Puckett M, Neri A, Underwood JM, Stewart SL (2016) Nutrition and physical activity strategies for cancer prevention in current National Comprehensive Cancer Control Program plans. J Community Health 41(5):1013–1020CrossRef Puckett M, Neri A, Underwood JM, Stewart SL (2016) Nutrition and physical activity strategies for cancer prevention in current National Comprehensive Cancer Control Program plans. J Community Health 41(5):1013–1020CrossRef
17.
go back to reference Randall LM, Pothuri B (2016) The genetic prediction of risk for gynecologic cancers. Gynecol Oncol 141(1):10–16CrossRef Randall LM, Pothuri B (2016) The genetic prediction of risk for gynecologic cancers. Gynecol Oncol 141(1):10–16CrossRef
18.
go back to reference Rim SH, Polonec L, Stewart SL, Gelb CA (2011) A national initiative for women and healthcare providers: CDC’s Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. J Women's Health (Larchmt) 20(11):1579–1585CrossRef Rim SH, Polonec L, Stewart SL, Gelb CA (2011) A national initiative for women and healthcare providers: CDC’s Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. J Women's Health (Larchmt) 20(11):1579–1585CrossRef
19.
go back to reference Rochester PW, Townsend JS, Given L, Krebill H, Balderrama S, Vinson C (2010) Comprehensive cancer control: progress and accomplishments. Cancer Causes Control 21(12):1967–1977CrossRef Rochester PW, Townsend JS, Given L, Krebill H, Balderrama S, Vinson C (2010) Comprehensive cancer control: progress and accomplishments. Cancer Causes Control 21(12):1967–1977CrossRef
20.
go back to reference Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, I. Writing Group for the Women's Health Initiative (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRef Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, I. Writing Group for the Women's Health Initiative (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRef
21.
go back to reference Schouten LJ, Goldbohm RA, van den Brandt PA (2006) Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study. Int J Gynecol Cancer 16(Suppl 2):492CrossRef Schouten LJ, Goldbohm RA, van den Brandt PA (2006) Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study. Int J Gynecol Cancer 16(Suppl 2):492CrossRef
22.
go back to reference Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, Sukumvanich P, Comerci J, Kelley J, LaPorte RE, Linkov F (2014) USA endometrial cancer projections to 2030: should we be concerned? Future Oncol 10(16):2561–2568CrossRef Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, Sukumvanich P, Comerci J, Kelley J, LaPorte RE, Linkov F (2014) USA endometrial cancer projections to 2030: should we be concerned? Future Oncol 10(16):2561–2568CrossRef
23.
go back to reference Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29CrossRef Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29CrossRef
24.
go back to reference Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, Puckett M, Richardson LC (2017) Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014. MMWR Morb Mortal Wkly Rep 66(39):1052–1058CrossRef Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, Puckett M, Richardson LC (2017) Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014. MMWR Morb Mortal Wkly Rep 66(39):1052–1058CrossRef
Metadata
Title
Increasing Awareness of Uterine Cancer Risks and Symptoms by Using Campaign Materials from Inside Knowledge: Get the Facts About Gynecologic Cancer
Authors
Daniel Novinson
Mary Puckett
Julie Townsend
Guillermo Tortolero-Luna
Jenny Rees Patterson
Cynthia A. Gelb
Sherri L. Stewart
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 6/2019
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-018-1427-4

Other articles of this Issue 6/2019

Journal of Cancer Education 6/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine